Testing effectiveness (Phase 2)Ended earlyNCT02872649
What this trial is testing
Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)
Who this might be right for
ThrombosisBleeding
Daniel Zimpfer, MD 16
Showing 7 of 7 results